Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
基本信息
- 批准号:8417645
- 负责人:
- 金额:$ 33.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-03 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acute PharyngitisAddressAnimal ModelAntibioticsC5a peptidaseCXC ChemokinesChemotaxisClinicalDataDevelopmentDiseaseGenesGeneticGoalsHumanHydrolysisIL8 geneImmuneImmune responseImmune systemIn VitroInfectionInfectious Skin DiseasesInflammationInterleukin-8InvestigationLicensingMediatingMedicalMolecularMusMutationNatural ImmunityNecrotizing fasciitisNeutrophil ActivationNeutrophil InfiltrationOrganismPathogenesisPatientsPatternPeptide HydrolasesPharyngitisPlatelet Activating FactorPlayPrevention therapyProductionRegulationRelative (related person)ResearchRoleSepsisSerotypingSiteSkinSoft Tissue InfectionsStreptococcal InfectionsStreptococcus pyogenesStreptococcus vaccineSystemTestingTimeVaccinesVariantVirulenceVirulence Factorsbaseesterasegenome-widein vivolipid mediatormigrationmouse modelmutantneutrophilnovelnovel strategiespathogenplatelet activating factor receptorpreventresponsestreptolysin Ssubcutaneous
项目摘要
DESCRIPTION (provided by applicant): Group A Streptococcus (GAS) is a major human pathogen that causes a variety of diseases, including relatively mild pharyngitis and skin infection and severe invasive infections such as sepsis and necrotizing fasciitis. Unfortunately, there is no licensed GAS vaccine, and severe invasive infections are difficult to treat with conventional antibiotics. A fundamental understanding of GAS pathogenesis is essential to the development of novel strategies to prevent and treat infections caused by this organism. The goal of this project is to clarify the mechanism for evasion of innate immunity by GAS. Based upon our preliminary studies, we hypothesize that the secreted esterase of GAS (designated SsE) plays a critical role in the inhibition of early neutrophil recruitment by GAS, which then allows the systemic spread of GAS to cause severe disease like sepsis. We further hypothesize that SsE hydrolyzes the platelet-activating factor and acts in tandem with other factor(s) to impede neutrophil responses. We pursue the following specific aims: (1) Determine whether SsE is required for inhibition of early neutrophil recruitment by GAS; (2) Determine whether SsE mediates inhibition of early neutrophil infiltration via hydrolysis of platelet-activating factor; nd (3) Test whether streptolysin S is responsible for the late collapse of neutrophil responses during subcutaneous infection of a sse mutant of a hypervirulent serotype M3 strain. The proposed studies promote two advancements. First, they will increase our understanding of GAS pathogenesis and progression of invasive GAS infections. Second, as a result, they will identify targets for development of a broad, efficacious GAS vaccine and new therapies for prevention and treatment of GAS infections. Overall, this project has the potential to define a novel mechanism for evasion of innate immunity by GAS and to establish a paradigm for bacterial inhibition of neutrophil recruitment and function.
描述(申请人提供):A族链球菌(GAS)是一种主要的人类病原体,可引起多种疾病,包括相对轻微的咽炎和皮肤感染以及严重的侵袭性感染,例如败血症和坏死性筋膜炎。不幸的是,目前还没有获得许可的 GAS 疫苗,并且严重的侵袭性感染很难用常规抗生素治疗。对 GAS 发病机制的基本了解对于制定预防和治疗该生物体引起的感染的新策略至关重要。该项目的目标是阐明 GAS 逃避先天免疫的机制。根据我们的初步研究,我们假设 GAS 分泌的酯酶(称为 SsE)在抑制 GAS 早期中性粒细胞募集方面发挥着关键作用,从而使 GAS 全身扩散,导致脓毒症等严重疾病。我们进一步假设 SsE 水解血小板激活因子并与其他因子协同作用以阻碍中性粒细胞反应。我们追求以下具体目标:(1)确定 SsE 是否是 GAS 抑制早期中性粒细胞募集所必需的; (2)确定SsE是否通过水解血小板活化因子介导抑制早期中性粒细胞浸润; nd (3) 测试链球菌溶血素 S 是否是高毒力血清型 M3 菌株的 sse 突变体皮下感染期间中性粒细胞反应晚期崩溃的原因。拟议的研究促进了两项进展。首先,它们将增加我们对 GAS 发病机制和侵袭性 GAS 感染进展的了解。其次,他们将确定开发广泛、有效的 GAS 疫苗和预防和治疗 GAS 感染的新疗法的目标。总体而言,该项目有可能定义一种通过 GAS 逃避先天免疫的新机制,并建立细菌抑制中性粒细胞募集和功能的范例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENFANG LEI其他文献
BENFANG LEI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENFANG LEI', 18)}}的其他基金
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10171774 - 财政年份:2020
- 资助金额:
$ 33.51万 - 项目类别:
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10040605 - 财政年份:2020
- 资助金额:
$ 33.51万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8297945 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8604673 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
9001240 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8788345 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8371028 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8495257 - 财政年份:2012
- 资助金额:
$ 33.51万 - 项目类别:
MT VET COBRE PROJECT 2: HEME UPTAKE PATHWAYS IN GRAM-POSITIVE PATHOGENS
MT VET COBRE 项目 2:革兰氏阳性病原体中的血红素摄取途径
- 批准号:
7960526 - 财政年份:2009
- 资助金额:
$ 33.51万 - 项目类别:
MT VET COBRE PROJECT 2: METAL UPTAKE AND REGULATION IN STREPTOCOCCUS PYOGENES
MT VET COBRE 项目 2:化脓性链球菌的金属吸收和调节
- 批准号:
7721026 - 财政年份:2008
- 资助金额:
$ 33.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.51万 - 项目类别:
Research Grant